Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease.

Roselli J, Innocenti T, Lynch EN, Parisio L, Macrì G, Milla M, Mello T, Galli A, Milani S, Tarocchi M.

Case Rep Gastrointest Med. 2020 Jan 28;2020:6726384. doi: 10.1155/2020/6726384. eCollection 2020.

PMID:
32082651
2.

Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist.

Myagmar BE, Ismaili T, Swigart PM, Raghunathan A, Baker AJ, Sahdeo S, Blevitt JM, Milla ME, Simpson PC.

Circ Res. 2019 Sep 13;125(7):699-706. doi: 10.1161/CIRCRESAHA.118.314416. Epub 2019 Aug 20.

PMID:
31426700
3.

Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center.

Dragoni G, Bagnoli S, Le Grazie M, Campani C, Rogai F, Manetti N, Bensi C, Macrì G, Galli A, Milla M.

J Dig Dis. 2019 May;20(5):235-242. doi: 10.1111/1751-2980.12748.

PMID:
30927309
4.

Hypoxia-preconditioned MSCs Have Superior Effect in Ameliorating Renal Function on Acute Renal Failure Animal Model.

Putra A, Pertiwi D, Milla MN, Indrayani UD, Jannah D, Sahariyani M, Trisnadi S, Wibowo JW.

Open Access Maced J Med Sci. 2019 Jan 30;7(3):305-310. doi: 10.3889/oamjms.2019.049. eCollection 2019 Feb 15.

5.

Incidence of Hypersensitivity Reactions During Hemodialysis.

Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E.

Kidney Blood Press Res. 2018;43(5):1472-1478. doi: 10.1159/000493662. Epub 2018 Sep 20.

6.

The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.

Nencini F, Vultaggio A, Pratesi S, Cammelli D, Milla M, Fiori G, Bagnoli S, Prignano F, Romagnani S, Maggi E, Matucci A.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2065-2072.e2. doi: 10.1016/j.jaip.2018.04.007. Epub 2018 Apr 13.

PMID:
29660428
7.

Heyde syndrome: Correction of anemia after aortic valve replacement in a hemodialysis patient.

Milla M, Hernández E, Mérida E, Yuste C, Rodríguez P, Praga M.

Nefrologia. 2018 May - Jun;38(3):327-329. doi: 10.1016/j.nefro.2017.05.002. Epub 2018 Mar 6. English, Spanish. No abstract available.

8.

Hyperkalemia of non-renal origin in a hemodialysis patient.

Rodríguez P, Mérida E, Hernández E, Milla M, Praga M.

Nefrologia. 2018 Jan - Feb;38(1):96-97. doi: 10.1016/j.nefro.2017.01.005. English, Spanish. No abstract available.

9.

Surface-enhanced infrared absorption with Si-doped InAsSb/GaSb nano-antennas.

Milla MJ, Barho F, González-Posada F, Cerutti L, Charlot B, Bomers M, Neubrech F, Tournie E, Taliercio T.

Opt Express. 2017 Oct 30;25(22):26651-26661. doi: 10.1364/OE.25.026651.

PMID:
29092159
10.

Cortical necrosis: An uncommon cause of acute renal failure with a very poor outcome.

Rodríguez PM, Morales E, Sánchez Á, Milla M, Martínez MA, Praga M.

Nefrologia. 2017 May - Jun;37(3):339-341. doi: 10.1016/j.nefro.2016.10.017. English, Spanish. No abstract available.

11.

Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study.

Daperno M, Bortoli A, Kohn A, Politi P, Marconi S, Ardizzone S, Cortelezzi CC, Grasso G, Ferraris L, Milla M, Spina L, Guidi L, Losco A, Inserra G, Sablich R, Morganti D, Bodini G, Comberlato M; Italian Group for the study of Inflammatory Bowel Disease IG-IBD.

Dig Liver Dis. 2017 Sep;49(9):997-1002. doi: 10.1016/j.dld.2017.05.008. Epub 2017 May 18.

PMID:
28595949
12.

Clinical characteristics of psoriasis in inflammatory bowel disease patients.

Pescitelli L, Gianotta M, Ricceri F, Lazzeri L, Milla M, Prignano F.

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e414-e416. doi: 10.1111/jdv.14230. Epub 2017 Apr 10. No abstract available.

PMID:
28319289
13.

Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction.

Blevitt JM, Hack MD, Herman KL, Jackson PF, Krawczuk PJ, Lebsack AD, Liu AX, Mirzadegan T, Nelen MI, Patrick AN, Steinbacher S, Milla ME, Lumb KJ.

J Med Chem. 2017 Apr 27;60(8):3511-3517. doi: 10.1021/acs.jmedchem.6b01836. Epub 2017 Mar 16.

PMID:
28300404
14.

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.

Abad S, Vega A, Hernández E, Mérida E, de Sequera P, Albalate M, Macías N, Milla M, López-Gómez JM.

Am J Nephrol. 2017;45(3):267-272. doi: 10.1159/000454819. Epub 2017 Jan 7.

PMID:
28166520
15.

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17.

PMID:
28161290
16.

Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo.

Wong E, Cohen T, Romi E, Levin M, Peleg Y, Arad U, Yaron A, Milla ME, Sagi I.

Sci Rep. 2016 Dec 16;6:35598. doi: 10.1038/srep35598.

17.

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients.

Abad S, Vega A, Rincón D, Hernández E, Mérida E, Macías N, Muñoz R, Milla M, Luño J, López-Gómez JM.

Nefrologia. 2017 Mar - Apr;37(2):158-163. doi: 10.1016/j.nefro.2016.10.003. Epub 2016 Nov 30. English, Spanish.

18.

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

Clin Exp Immunol. 2016 Dec;186(3):364-372. doi: 10.1111/cei.12858. Epub 2016 Oct 26.

19.

Localized surface plasmon resonance frequency tuning in highly doped InAsSb/GaSb one-dimensional nanostructures.

Milla MJ, Barho F, González-Posada F, Cerutti L, Bomers M, Rodriguez JB, Tournié E, Taliercio T.

Nanotechnology. 2016 Oct 21;27(42):425201. doi: 10.1088/0957-4484/27/42/425201. Epub 2016 Sep 8.

PMID:
27608135
20.

Bio-identity and fate of albumin-coated SPIONs evaluated in cells and by the C. elegans model.

Yu SM, Gonzalez-Moragas L, Milla M, Kolovou A, Santarella-Mellwig R, Schwab Y, Laromaine A, Roig A.

Acta Biomater. 2016 Oct 1;43:348-357. doi: 10.1016/j.actbio.2016.07.024. Epub 2016 Jul 15.

PMID:
27427227
21.

A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors.

Blevitt JM, Hack MD, Herman K, Chang L, Keith JM, Mirzadegan T, Rao NL, Lebsack AD, Milla ME.

J Biol Chem. 2016 Jun 10;291(24):12724-31. doi: 10.1074/jbc.M116.725325. Epub 2016 Apr 16.

22.

Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-throughput Lipidomics Platform.

Song J, Liu X, Zhu J, Tootoonchi M, Keith JM, Meduna SP, Dvorak CA, Eccles W, Krawczuk PJ, Blevitt JM, Wu J, Rao NL, Lebsack AD, Milla ME.

J Biomol Screen. 2016 Feb;21(2):127-35. doi: 10.1177/1087057115607815. Epub 2015 Oct 6.

PMID:
26442913
23.

Phenotyping drug polypharmacology via eicosanoid profiling of blood.

Song J, Liu X, Rao TS, Chang L, Meehan MJ, Blevitt JM, Wu J, Dorrestein PC, Milla ME.

J Lipid Res. 2015 Aug;56(8):1492-500. doi: 10.1194/jlr.M058677. Epub 2015 May 28.

24.

Phenotypic Approaches to Identify Inhibitors of B Cell Activation.

Rex EB, Kim S, Wiener J, Rao NL, Milla ME, DiSepio D.

J Biomol Screen. 2015 Aug;20(7):876-86. doi: 10.1177/1087057115585724. Epub 2015 May 6.

25.

Thrombosis in inflammatory bowel diseases: what's the link?

Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M.

Thromb J. 2015 Apr 2;13:14. doi: 10.1186/s12959-015-0044-2. eCollection 2015.

26.

Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.

Copik AJ, Baldys A, Nguyen K, Sahdeo S, Ho H, Kosaka A, Dietrich PJ, Fitch B, Raymond JR, Ford AP, Button D, Milla ME.

PLoS One. 2015 Jan 21;10(1):e0115701. doi: 10.1371/journal.pone.0115701. eCollection 2015.

27.

Photoexcited-induced sensitivity of InGaAs surface QDs to environment.

Milla MJ, Ulloa JM, Guzmán A.

Nanotechnology. 2014 Nov 7;25(44):445501. doi: 10.1088/0957-4484/25/44/445501. Epub 2014 Oct 17.

PMID:
25325146
28.

Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis.

Bandinelli F, Terenzi R, Giovannini L, Milla M, Genise S, Bagnoli S, Biagini S, Annese V, Matucci-Cerinic M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):949-52. Epub 2014 Aug 15.

PMID:
25152017
29.

Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation.

Soroosh P, Wu J, Xue X, Song J, Sutton SW, Sablad M, Yu J, Nelen MI, Liu X, Castro G, Luna R, Crawford S, Banie H, Dandridge RA, Deng X, Bittner A, Kuei C, Tootoonchi M, Rozenkrants N, Herman K, Gao J, Yang XV, Sachen K, Ngo K, Fung-Leung WP, Nguyen S, de Leon-Tabaldo A, Blevitt J, Zhang Y, Cummings MD, Rao T, Mani NS, Liu C, McKinnon M, Milla ME, Fourie AM, Sun S.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12163-8. doi: 10.1073/pnas.1322807111. Epub 2014 Aug 4.

30.

Characterization of RO5126946, a Novel α7 nicotinic acetylcholine receptor-positive allosteric modulator.

Sahdeo S, Wallace T, Hirakawa R, Knoflach F, Bertrand D, Maag H, Misner D, Tombaugh GC, Santarelli L, Brameld K, Milla ME, Button DC.

J Pharmacol Exp Ther. 2014 Aug;350(2):455-68. doi: 10.1124/jpet.113.210963. Epub 2014 Jun 10.

PMID:
24917542
31.

Strong influence of the humidity on the electrical properties of InGaAs surface quantum dots.

Milla MJ, Ulloa JM, Guzmán Á.

ACS Appl Mater Interfaces. 2014 May 14;6(9):6191-5. doi: 10.1021/am5010442. Epub 2014 Apr 28.

PMID:
24764178
32.

Role of vitamin D derivatives in intestinal tissue of patients with inflammatory bowel diseases.

Martinesi M, Ambrosini S, Treves C, Zuegel U, Steinmeyer A, Vito A, Milla M, Bonanomi AG, Stio M.

J Crohns Colitis. 2014 Sep;8(9):1062-71. doi: 10.1016/j.crohns.2014.02.005. Epub 2014 Mar 12.

PMID:
24630484
33.

Welfare Homes for Patients Living with HIV/AIDS in Andalusia.

Ivanova R, Vergara S, Milla M, Lozano F, Santos J.

J Int Assoc Provid AIDS Care. 2014 Sep-Oct;13(5):393-6. doi: 10.1177/2325957413508322. Epub 2013 Oct 25.

PMID:
24162615
34.

Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab.

Matucci A, Pratesi S, Petroni G, Nencini F, Virgili G, Milla M, Maggi E, Vultaggio A.

Clin Exp Allergy. 2013 Jun;43(6):659-64. doi: 10.1111/cea.12098.

PMID:
23711128
35.

Adalimumab in active ulcerative colitis: a "real-life" observational study.

Italian Group for the Study of Inflammatory Bowel Disease, Armuzzi A, Biancone L, Daperno M, Coli A, Pugliese D, Annese V, Aratari A, Ardizzone S, Balestrieri P, Bossa F, Cappello M, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Orlando A, Papparella LG, Renna S, Ricci C, Rizzello F, Sostegni R, Guidi L, Papi C.

Dig Liver Dis. 2013 Sep;45(9):738-43. doi: 10.1016/j.dld.2013.03.018. Epub 2013 May 15.

36.

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Burisch J, Pedersen N, Čuković-Čavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.

PMID:
23604131
37.

[Study on the professional procedures, experiences and needs of parents when they are told their child has a disability or developmental disorder. Breaking the news].

Ponte J, Perpiñán S, Mayo ME, Millá MG, Pegenaute F, Poch-Olivé ML.

Rev Neurol. 2012 Feb 29;54 Suppl 1:S3-9. Review. Spanish.

38.

A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood.

Song J, Liu X, Wu J, Meehan MJ, Blevitt JM, Dorrestein PC, Milla ME.

Anal Biochem. 2013 Feb 15;433(2):181-8. doi: 10.1016/j.ab.2012.10.022. Epub 2012 Oct 26.

PMID:
23103340
39.

Transfer of carboplatin and paclitaxel into breast milk.

Griffin SJ, Milla M, Baker TE, Liu T, Wang H, Hale TW.

J Hum Lact. 2012 Nov;28(4):457-9. doi: 10.1177/0890334412459374.

PMID:
23087196
40.

Molecular analysis of model gut microbiotas by imaging mass spectrometry and nanodesorption electrospray ionization reveals dietary metabolite transformations.

Rath CM, Alexandrov T, Higginbottom SK, Song J, Milla ME, Fischbach MA, Sonnenburg JL, Dorrestein PC.

Anal Chem. 2012 Nov 6;84(21):9259-67. doi: 10.1021/ac302039u. Epub 2012 Oct 10.

41.

Self-assembly of thin plates from micrococcal nuclease-digested chromatin of metaphase chromosomes.

Milla M, Daban JR.

Biophys J. 2012 Aug 8;103(3):567-75. doi: 10.1016/j.bpj.2012.06.028.

42.

Circumferential peptic ulceration from Meckel diverticulum by capsule endoscopy.

Montemaggi A, Paci M, Barp J, Milla M, Lionetti P.

J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):1. doi: 10.1097/MPG.0b013e31822d301e. No abstract available.

PMID:
21788914
43.

INTRACELLULAR METAL COMPARTMENTALIZATION IN THE GREEN ALGAL MODEL SYSTEM MICRASTERIAS DENTICULATA (STREPTOPHYTA) MEASURED BY TRANSMISSION ELECTRON MICROSCOPY-COUPLED ELECTRON ENERGY LOSS SPECTROSCOPY1.

Volland S, Andosch A, Milla M, Stöger B, Lütz C, Lütz-Meindl U.

J Phycol. 2011 Jun;47(3):565-579. doi: 10.1111/j.1529-8817.2011.00988.x. Epub 2011 May 16.

PMID:
27021986
44.

Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy.

Bandinelli F, Milla M, Genise S, Giovannini L, Bagnoli S, Candelieri A, Collaku L, Biagini S, Cerinic MM.

Rheumatology (Oxford). 2011 Jul;50(7):1275-9. doi: 10.1093/rheumatology/keq447. Epub 2011 Feb 10.

PMID:
21317135
45.

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD.

Nat Genet. 2011 Mar;43(3):246-52. doi: 10.1038/ng.764. Epub 2011 Feb 6. Erratum in: Nat Genet. 2011 Sep;43(9):919.

46.

Pachymetric measurements with a new Scheimpflug photography-based system: intraobserver repeatability and agreement with optical coherence tomography pachymetry.

Milla M, Piñero DP, Amparo F, Alió JL.

J Cataract Refract Surg. 2011 Feb;37(2):310-6. doi: 10.1016/j.jcrs.2010.08.038.

PMID:
21241914
47.

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

Gever JR, Soto R, Henningsen RA, Martin RS, Hackos DH, Panicker S, Rubas W, Oglesby IB, Dillon MP, Milla ME, Burnstock G, Ford AP.

Br J Pharmacol. 2010 Jul;160(6):1387-98. doi: 10.1111/j.1476-5381.2010.00796.x.

48.

Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases.

Martinesi M, Treves C, Bonanomi AG, Milla M, Bagnoli S, Zuegel U, Steinmeyer A, Stio M.

Clin Immunol. 2010 Jul;136(1):51-60. doi: 10.1016/j.clim.2010.03.004. Epub 2010 Apr 15.

PMID:
20399147
49.

Irregular orientation of nucleosomes in the well-defined chromatin plates of metaphase chromosomes.

Castro-Hartmann P, Milla M, Daban JR.

Biochemistry. 2010 May 18;49(19):4043-50. doi: 10.1021/bi100125f.

PMID:
20369829
50.

[Models of intervention in children with autism].

Mulas F, Ros-Cervera G, Millá MG, Etchepareborda MC, Abad L, Téllez de Meneses M.

Rev Neurol. 2010 Mar 3;50 Suppl 3:S77-84. Review. Spanish.

Supplemental Content

Support Center